tadalafil has been researched along with Memory Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otari, KV; Patil, RJ; Upasani, CD | 1 |
| Bhatia, P; Singh, N | 1 |
| Akhtar, M; Hasan, N; Najmi, AK; Parvez, S; Yar, MS; Zameer, S | 1 |
| Araújo, SMR; Duarte-Silva, E; França, MER; Lós, DB; Oliveira, WH; Peixoto, CA; Ramos, RKLG | 1 |
| Gulati, P; Singh, N | 1 |
| Baek, SB; Bahn, G; Kim, BK; Kim, CJ; Kim, KH; Kim, SE; Kim, TS; Ko, IG; Lee, J; Moon, SJ; Shin, MS; Sung, YH | 1 |
6 other study(ies) available for tadalafil and Memory Disorders
| Article | Year |
|---|---|
Improvement of cognitive dysfunction by a novel phosphodiesterase type 5 inhibitor, Tadalafil.
Topics: Cognitive Dysfunction; Cyclic GMP; Humans; Memory Disorders; NG-Nitroarginine Methyl Ester; Phosphodiesterase 5 Inhibitors; Scopolamine; Tadalafil | 2023 |
Tadalafil ameliorates memory deficits, oxidative stress, endothelial dysfunction and neuropathological changes in rat model of hyperhomocysteinemia induced vascular dementia.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Brain; Cyclic Nucleotide Phosphodiesterases, Type 5; Dementia, Vascular; Hyperhomocysteinemia; Maze Learning; Memory Disorders; Methionine; Nitrites; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Tadalafil | 2022 |
Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway.
Topics: Alzheimer Disease; Aminopyridines; Amyloid beta-Peptides; Animals; Benzamides; Brain-Derived Neurotrophic Factor; Cyclic AMP; Cyclic GMP; Cyclopropanes; Cytokines; Gene Expression Regulation; Hippocampus; Male; Memory Disorders; Morris Water Maze Test; Oxidative Stress; Peptide Fragments; Random Allocation; Rats; Rats, Wistar; Tadalafil; Vasodilator Agents | 2021 |
Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy.
Topics: Animals; Astrocytes; Blotting, Western; CA1 Region, Hippocampal; Cerebral Cortex; Cytokines; Disease Models, Animal; Fluorescent Antibody Technique; Hepatic Encephalopathy; Injections, Intraperitoneal; Memory Disorders; Memory, Long-Term; Mice; Microglia; Neuronal Plasticity; Neuroprotective Agents; Nitric Oxide; Spatial Learning; Tadalafil; Thioacetamide | 2019 |
Tadalafil enhances the neuroprotective effects of ischemic postconditioning in mice, probably in a nitric oxide associated manner.
Topics: Animals; Ataxia; Brain; Brain Ischemia; Carbolines; Cerebral Infarction; Cyclic Nucleotide Phosphodiesterases, Type 5; Ischemic Postconditioning; Male; Memory Disorders; Mice; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase 5 Inhibitors; Reperfusion Injury; Tadalafil | 2014 |
The phosphodiesterase type-5 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal-separated rat pups.
Topics: Age Factors; Animals; Animals, Newborn; Apoptosis; Avoidance Learning; Bromodeoxyuridine; Carbolines; Caspase 3; Cell Proliferation; Dentate Gyrus; Depression; Disease Models, Animal; DNA Fragmentation; Female; Freezing Reaction, Cataleptic; In Situ Nick-End Labeling; Maternal Deprivation; Memory Disorders; Phosphodiesterase 5 Inhibitors; Pregnancy; Rats; Rats, Sprague-Dawley; Reaction Time; Swimming; Tadalafil | 2011 |